Related Experiment Video
Updated: Feb 7, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer
Reyhaneh Moradi-Marjaneh1, Majid Khazaei2, Sima Seifi2,3
1Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Inter-individual differences in drug response are an important cause of failure in anticancer treatment and adverse drug events in cancer patients. Gene polymorphisms related to these outcomes have been investigated in an effort to find new genetic biomarkers to predict toxicity and response to anticancer drugs. Evaluating the value single nucleotide polymorphisms (SNPs) in the genes involved in transportation, activation and metabolism of anticancer drugs provides a promising approach to select the appropriate therapeutic regimes with at least adverse reactions. This review summarizes the current knowledge about the relationship between of SNPs involved in the transportation, activation and metabolism of anticancer drugs and treatment outcomes in colorectal cancer (CRC) patients.
Insights
Genetic variations called single nucleotide polymorphisms (SNPs) influence how colorectal cancer patients respond to chemotherapy. Identifying these SNPs can help predict treatment outcomes and minimize adverse drug reactions.
Area of Science:
- Pharmacogenomics
- Oncology
- Genetics
Background:
- Inter-individual variability in anticancer drug response contributes to treatment failure and adverse drug events.
- Genetic biomarkers are sought to predict patient toxicity and response to chemotherapy.
- Single nucleotide polymorphisms (SNPs) in drug-metabolizing, -transporting, and -activating genes are key areas of investigation.
Purpose of the Study:
- To review the current knowledge on the association between SNPs in genes related to anticancer drug handling and treatment outcomes in colorectal cancer (CRC) patients.
- To highlight the potential of SNPs as predictive biomarkers for optimizing CRC therapy.
Main Methods:
- Literature review of studies investigating SNPs in genes involved in drug transport, activation, and metabolism.
- Focus on studies related to colorectal cancer (CRC) treatment outcomes.
- Synthesis of current evidence on the clinical utility of these genetic markers.
Main Results:
- SNPs in genes responsible for drug metabolism, transport, and activation are linked to varying responses and toxicities in CRC patients.
- Certain SNP profiles may predict efficacy and risk of adverse events, guiding personalized treatment strategies.
- The review consolidates findings on specific SNPs and their impact on chemotherapy outcomes in CRC.
Conclusions:
- Evaluating SNPs in drug-related genes offers a promising approach for personalized medicine in colorectal cancer.
- Genetic profiling can aid in selecting optimal therapeutic regimens with reduced adverse reactions.
- Further research into SNP-drug interactions is crucial for advancing precision oncology in CRC treatment.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Cancer
Urine Studies II: Urine Culture and Sensitivity Test
Pharmacokinetics: Drug–Drug Interactions

